A protein called uPAR may be a target for new cancer treatments
Original title: uPAR-directed immunotherapies in solid tumors: current advances and future perspectives.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a review of where the research is heading, not a treatment people can get.
The short version
Scientists are looking at a protein on tumor cells as a way to attack hard to treat cancers.
What was studied. This is a review article. It pulls together past lab and animal research on a protein called uPAR, which shows up in several solid tumors, including glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary.
What they found. Tumors with high levels of uPAR tend to grow faster and spread more. They also resist standard treatment more often. uPAR sits on tumor cells and on nearby cells that help the tumor hide from the immune system. Blocking or removing uPAR slowed tumor growth in lab and animal tests.
What this means, and what it doesn't
What it could mean: uPAR could become a target for future treatments in tumors that are hard to treat, like glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary. Several methods are being tried, such as CAR T cell therapy, vaccines, antibodies, and drugs that carry radiation. None of these is something a patient can get for this purpose today.
What it doesn't mean: This is not a new study result in people. It is a summary of where the science stands and why researchers think this target is worth trying. The treatments it describes are still being worked on. They have not been shown to help people with brain tumors. This is not a promise of a cure.
Source: PubMed, September 21, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.